Clinical Trials Browser

Phase 1 × Advanced Cancers × Everolimus × Clear all

NCT01430572 2023-06-06

Pazopanib and Everolimus in PI3KCA Mutation Positive/PTEN Loss Patients

Phase 1 Completed

Other solid neoplasm

Advanced Cancers